Viewing nowCombinationTenelia M Extended-Release Tablets 10/750 mg
Metformin Hydrochloride 750mg · Teneligliptin Hydrobromide Hydrate 15.5mg
Tablet · Prescription medication · Combination
HanDoc Co., Ltd.

MFDS item code 201501697 · Approved 2015.03.31 · Insurance code 652105470
Improvement of blood glucose control in patients with type 2 diabetes
This medication is used in conjunction with dietary adjustments and physical therapy to assist patients with type 2 diabetes in controlling their blood sugar levels. Teneligliptin and metformin work together to effectively lower blood sugar levels. It is used as a beneficial adjunct therapy for patients who find it challenging to control their blood sugar.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide a dose of teneligliptin 20 mg once daily and the patient's existing metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately. When administered concomitantly with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Because changes may lead to alterations in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, this medicine should be swallowed whole without splitting, crushing, grinding, or chewing.
This medication is used for the treatment of diabetes and helps in controlling blood sugar. However, caution must be exercised as rare side effects like severe lactic acidosis can occur with this medication. Patients with impaired kidney function, heart diseases, or liver dysfunction should not take this medication. Additionally, since this medication can cause hypoglycemia, special care should be taken when taken alongside insulin or other hypoglycemic agents. Patients about to undergo surgery or those scheduled for radiological contrast examinations should temporarily discontinue use of this medication and should restart only after confirming normal kidney function following the tests. Women who are pregnant or may become pregnant are advised against using this medication. This medication can occasionally cause gastrointestinal disturbances, dizziness, headaches, skin rashes, and if any unusual symptoms occur, consulting a physician is advised. Moreover, it may cause a decrease in vitamin B12 levels, thus regular blood tests for monitoring are important. It is also recommended to avoid alcohol while taking this medication, and if sudden vomiting, diarrhea, or dehydration occurs, consult a physician immediately. Elderly patients may have impaired kidney function and should regularly check kidney function before and during treatment. Finally, during the use of this medication, be well-informed about the symptoms of hypoglycemia and exercise caution when performing hazardous tasks such as driving or working at heights.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture exposure, and kept at room temperature between 1 and 30 degrees Celsius. Proper storage can maintain the drug's effectiveness over time.
Yellow oval-shaped extended-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 750mg · Teneligliptin Hydrobromide Hydrate 15.5mg
Tablet · Prescription medication · Combination
HanDoc Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Teneligliptin Hydrobromide Hydrate 15.5mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Hydrobromide Hydrate 31mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.